| AXA IM GLOBAL EMERGING MARKETS EQUITY QI B USD ACC | RVI EMERGENTES | 39,71% | 79,67% | 66,86% | 140,66% |
| GOLDMAN SACHS GLOBAL EQUITY PARTNERS ESG PORTFOLIO BASE H USD DIS | RVI GLOBAL | 10,04% | 26,34% | 24,34% | 140,63% |
| CAPITAL GROUP EUROPEAN CORE EQUITY FUND (LUX) C EUR | RVI EUROPA VALOR | 25,03% | 52,26% | 65,28% | 140,57% |
| FRANKLIN BIOTECHNOLOGY DISCOVERY A (ACC) HKD | RVI BIOTECNOLOGÍA | 71,14% | 97,54% | 73,81% | 140,53% |
| FRANKLIN BIOTECHNOLOGY DISCOVERY A (ACC) USD | RVI BIOTECNOLOGÍA | 71,14% | 97,67% | 73,84% | 140,52% |
| UBS (LUX) EQUITY FUND - EUROPEAN OPPORTUNITY (EUR) (USD HEDGED) P-ACC | RVI EUROPA | 30,90% | 40,72% | 45,58% | 140,50% |
| PICTET - JAPANESE EQUITY SELECTION I JPY | RVI JAPÓN | 28,19% | 44,60% | 46,34% | 140,49% |
| LO FUNDS - SWISS EQUITY (CHF) M CAP | RVI SUIZA | 15,08% | 34,45% | 29,60% | 140,48% |
| GUINNESS SUSTAINABLE ENERGY FUND C EUR ACC | RVI ENERGÍA | 25,27% | 10,29% | 6,73% | 140,45% |
| GOLDMAN SACHS GLOBAL EQUITY PARTNERS ESG PORTFOLIO BASE H USD CAP | RVI GLOBAL | 10,00% | 26,31% | 24,23% | 140,42% |
